Longliv Ventures

ApoWiser is a digital health company specializing in personalized over-the-counter (OTC) medication and vitamin recommendations. It uses advanced business intelligence systems to provide tailored guidance based on individual health profiles, enhancing consumer engagement and navigation of the online marketplace.

AceAge is a healthcare technology company focused on creating innovative solutions to enhance health outcomes and ease the aging process. The company's flagship product, a home health appliance named Karie, serves as a personal health companion that organizes, schedules, and dispenses medications with a simple one-button interface. Designed to improve patient compliance with medication regimens, Karie aims to reduce the negative impacts associated with missed doses. By automating daily medication routines, the device minimizes human error and promotes greater patient autonomy. Karie utilizes standard multi-dose pouch packaging that can be pre-configured by pharmacists, ensuring that doses are effectively scheduled, delivered, and monitored. Through its technology, AceAge seeks to improve healthcare delivery and reduce the substantial costs associated with medication nonadherence, ultimately supporting better health outcomes for patients.

Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that specializes in blood diagnostics using advanced computer vision technology. The company focuses on improving health outcomes with rapid, accurate, and convenient diagnostic solutions. His flagship product, Parasight, is a malaria detection device that has performed nearly one million tests across 24 countries, though it is not available for sale in the United States. Sight Diagnostics has also developed Sight OLO, an FDA-cleared blood analyzer that requires only two drops of blood to deliver lab-grade Complete Blood Count results within minutes. Combining machine vision, AI, and innovations in multiple scientific fields, Sight Diagnostics aims to facilitate effective healthcare delivery and expand its commercial presence across five continents.

DayTwo Ltd. is a precision nutrition company based in Tel Aviv-Yafo, Israel, that focuses on leveraging gut microbiome analysis to provide tailored health solutions for metabolic diseases such as diabetes, prediabetes, clinical obesity, and non-alcoholic fatty liver disease (NAFLD). Founded in 2015, DayTwo utilizes a web-based platform that offers personalized dietary recommendations through its innovative Food Prescriptions™, which are designed to help individuals manage their blood sugar levels and improve overall health. By sequencing gut microbiomes, the company identifies how different foods affect each person, allowing for customized nutrition plans. DayTwo's virtual care model is supported by Certified Diabetes Care and Education Specialists and Registered Dietitians, who engage with patients through a smartphone application to track progress and ensure adherence to the dietary recommendations.

DayTwo Ltd. is a precision nutrition company based in Tel Aviv-Yafo, Israel, that focuses on leveraging gut microbiome analysis to provide tailored health solutions for metabolic diseases such as diabetes, prediabetes, clinical obesity, and non-alcoholic fatty liver disease (NAFLD). Founded in 2015, DayTwo utilizes a web-based platform that offers personalized dietary recommendations through its innovative Food Prescriptions™, which are designed to help individuals manage their blood sugar levels and improve overall health. By sequencing gut microbiomes, the company identifies how different foods affect each person, allowing for customized nutrition plans. DayTwo's virtual care model is supported by Certified Diabetes Care and Education Specialists and Registered Dietitians, who engage with patients through a smartphone application to track progress and ensure adherence to the dietary recommendations.

Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that specializes in blood diagnostics using advanced computer vision technology. The company focuses on improving health outcomes with rapid, accurate, and convenient diagnostic solutions. His flagship product, Parasight, is a malaria detection device that has performed nearly one million tests across 24 countries, though it is not available for sale in the United States. Sight Diagnostics has also developed Sight OLO, an FDA-cleared blood analyzer that requires only two drops of blood to deliver lab-grade Complete Blood Count results within minutes. Combining machine vision, AI, and innovations in multiple scientific fields, Sight Diagnostics aims to facilitate effective healthcare delivery and expand its commercial presence across five continents.